Videum
 
 
24/7 Health and Wellness
24/7 Health and Wellness

24/7 Health and Wellness

To keep healthy, stay informed with Health Medical Publication Group

0 Followers
Share
4943

Hepatitis C News to be Expected in November (AASLD) VRTX MRK BMY GILD JNJ

Hepatitis C and liver infections offer a lot of room for improvement, and as such have become a large area of development for Biotech and Pharma. The market is fairly developed but currently the standard of care is insufficient and therapies are hard to take. While Vertex and Merck are in the lead, Mark Schoenebaum is mostly in the 3rd, 4th, and 5th place sprinters that are 1-3 years behind and for whom the story hasn't necessarily been told. [via BioBusinessTV]

Duration: 03:16
Original Language: English
Published: 9/20/2013
Diseases and Conditions: Hepatitis

Other videos in this channel

 

Related Videos

Hepatitis C News to be Expected in November (AASLD) VRTX MRK BMY GILD JNJ

Comments (0)

Login to add your comment
Be the first to comment!